X4 Pharmaceuticals's market cap is currently $77.67M. The company's EPS TTM is $-3.47; its P/E ratio is 0.66; X4 Pharmaceuticals is scheduled to report earnings on July 31, 2025, and the estimated EPS forecast is $-0.55. See an overview of income statement, balance sheet, and cash flow financials.
